Skip to main content
Clinical Trials/NCT05729763
NCT05729763
Completed
Not Applicable

Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational Study

San Luigi Gonzaga Hospital1 site in 1 country300 target enrollmentJune 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Neoplasms
Sponsor
San Luigi Gonzaga Hospital
Enrollment
300
Locations
1
Primary Endpoint
PADUA nephrometry score calculated via 3D virtual modelling and standard bidimensional CT scan images
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

STUDY DESIGN:

prospective multicentric observational

SAMPLE SIZE OF THE STUDY:

The estimated number of patients to enroll in the multicenter study is at least 270 patients (statistically calculated referring to the results of a monocentric analysis including 101 patients with the same design, already performed by the Coordinator Center).

NUMBER OF CENTERS INVOLVED:

Considering a total number of patients enrolled of at least 270, number of Centers to be involved: 5.

STUDY PROCEDURES:

3D virtual model rendering

  • CT-scan images sent in DICOM format to MEDICS (Turin, Italy) after anonymization.
  • Dedicated online platform available to upload the anonymized CT images, after registration.
  • CT imaging processing by bioengineers and 3DVM building within 72 hours
  • 3D-PDF download from the same online platform

Nephrometric score assessment

  • All CT-scans and their 3DVMsevaluation in order to assess surgical complexity, as classified by the PADUA nephrometry score and its relative PADUA risk category.

  • For each Center:

    • assessment of the PADUA score on the basis of the CT-scans (2D-NS) by one urologist;
    • assessment of the PADUA score on the basis of the 3DVMs (3D-NS) by another urologist.

Surgical intervention and pathological assessment

  • Dedicated expert surgeon for each Center performing NSS to all patients with the same surgical technique.
  • Dedicated uro-pathologist for each Center performing the histopathological evaluations of the specimens.
Registry
clinicaltrials.gov
Start Date
June 1, 2019
End Date
September 30, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
San Luigi Gonzaga Hospital
Responsible Party
Principal Investigator
Principal Investigator

Francesco Porpiglia

Prof.

San Luigi Gonzaga Hospital

Eligibility Criteria

Inclusion Criteria

  • four-phase (unenhanced, corticomedullary, nephrographic and urographic phases) contrast enhanced CT-scan

Exclusion Criteria

  • evidence of anatomical abnormalities, like horse-shoe shaped or ectopic kidney.
  • preoperative imaging inadequate to perform a 3DVM (such as those with a CT-scan with \>3 mm acquisition interval of the slices, or suboptimal difference of enhancement among the enhanced phases) or older than 3 months.

Outcomes

Primary Outcomes

PADUA nephrometry score calculated via 3D virtual modelling and standard bidimensional CT scan images

Time Frame: Baseline

The PADUA nephrometry score predicts the risk of surgical and medical perioperative complications in patients who underwent partial nephrectomy. The PADUA nephrometry score evaluates different tumor characteristics: * Longitudinal (polar) location (Superior/inferior: 1pt; Middle: 2 pt), * Exophytic rate (\>=50%: 1pt; \<50%: 2pt; Endophytic: 3pt) * Renal rim (Lateral: 1pt; Medial: 2pt) * Renal sinus (Not involved: 1pt; Involved: 2pt) * Urinary collecting system (Not involved: 1pt; Dislocated/infiltrated: 2pt) * Tumor size (\<=4 cm: 1pt; 4.1-7 cm: 2pt; \>7: 3pt) The PADUA score, calculated as the sum of these parameters, stratify patients from PADUA 6 tumors, that have low risk of complications, to PADUA 14, with high risk of perioperative complications.

Secondary Outcomes

  • To compare the occurrence of postoperative complications, assessed by Clavien-Dindo classification(90 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials